Vision and Goals


Saniona will be a leading biotech company focussing on treatments for CNS, autoimmune and metabolic diseases as well as the treatment of pain. 


Saniona’s overall objective is to develop new treatments both in-house and together with partners that address significant unmet needs.

Business idea

Strategically the company intends to develop and commercialize treatments for orphan indications on its own and engage in partnerships with larger entities for development programs aiming to treat large indications such as obesity.